Adherium Brings In MicroDose Co-Founder As Senior VP
SmartInhaler developer Adherium has appointed the co-founder of MicroDose Therapeutx to head up its European base in Amsterdam, Netherlands.
You may also be interested in...
Developer of the SmartInhaler, Adherium Ltd, has established a European subsidiary which will be headed by John Tarplee, a veteran of the pharmaceutical industry with over 30 years’ experience. As Senior Vice-President Business development, Europe, Tarplee will lead market development and partnering activities in that region.
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.